BCYC
Price
$7.50
Change
+$0.33 (+4.60%)
Updated
Jul 8 closing price
Capitalization
519.4M
22 days until earnings call
TVTX
Price
$15.30
Change
+$0.70 (+4.79%)
Updated
Jul 8 closing price
Capitalization
1.36B
22 days until earnings call
Interact to see
Advertisement

BCYC vs TVTX

Header iconBCYC vs TVTX Comparison
Open Charts BCYC vs TVTXBanner chart's image
Bicycle Therapeutics
Price$7.50
Change+$0.33 (+4.60%)
Volume$209.09K
Capitalization519.4M
Travere Therapeutics
Price$15.30
Change+$0.70 (+4.79%)
Volume$1.43M
Capitalization1.36B
BCYC vs TVTX Comparison Chart in %
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. TVTX commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Buy and TVTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (BCYC: $7.50 vs. TVTX: $15.30)
Brand notoriety: BCYC and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 68% vs. TVTX: 87%
Market capitalization -- BCYC: $519.4M vs. TVTX: $1.36B
BCYC [@Biotechnology] is valued at $519.4M. TVTX’s [@Biotechnology] market capitalization is $1.36B. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileTVTX’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • TVTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both BCYC and TVTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 7 TA indicator(s) are bullish while TVTX’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 7 bullish, 3 bearish.
  • TVTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than TVTX.

Price Growth

BCYC (@Biotechnology) experienced а +6.69% price change this week, while TVTX (@Biotechnology) price change was +4.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

BCYC is expected to report earnings on Oct 30, 2025.

TVTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TVTX($1.36B) has a higher market cap than BCYC($519M). TVTX YTD gains are higher at: -12.170 vs. BCYC (-46.429). TVTX has higher annual earnings (EBITDA): -168.21M vs. BCYC (-200.61M). BCYC has more cash in the bank: 793M vs. TVTX (322M). BCYC has less debt than TVTX: BCYC (8.33M) vs TVTX (400M). TVTX has higher revenues than BCYC: TVTX (274M) vs BCYC (25.7M).
BCYCTVTXBCYC / TVTX
Capitalization519M1.36B38%
EBITDA-200.61M-168.21M119%
Gain YTD-46.429-12.170382%
P/E RatioN/AN/A-
Revenue25.7M274M9%
Total Cash793M322M246%
Total Debt8.33M400M2%
FUNDAMENTALS RATINGS
BCYC vs TVTX: Fundamental Ratings
BCYC
TVTX
OUTLOOK RATING
1..100
7312
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
87
Overvalued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
6553
P/E GROWTH RATING
1..100
10046
SEASONALITY SCORE
1..100
2930

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCYC's Valuation (20) in the null industry is significantly better than the same rating for TVTX (87) in the Biotechnology industry. This means that BCYC’s stock grew significantly faster than TVTX’s over the last 12 months.

TVTX's Profit vs Risk Rating (98) in the Biotechnology industry is in the same range as BCYC (100) in the null industry. This means that TVTX’s stock grew similarly to BCYC’s over the last 12 months.

BCYC's SMR Rating (96) in the null industry is in the same range as TVTX (100) in the Biotechnology industry. This means that BCYC’s stock grew similarly to TVTX’s over the last 12 months.

TVTX's Price Growth Rating (53) in the Biotechnology industry is in the same range as BCYC (65) in the null industry. This means that TVTX’s stock grew similarly to BCYC’s over the last 12 months.

TVTX's P/E Growth Rating (46) in the Biotechnology industry is somewhat better than the same rating for BCYC (100) in the null industry. This means that TVTX’s stock grew somewhat faster than BCYC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCYCTVTX
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEYCX27.89N/A
N/A
Fidelity Advisor Asset Manager 85% C
SLPIX111.46N/A
N/A
ProFunds Small Cap Inv
TRMVX27.27N/A
N/A
SEI Large Cap Value F (SIMT)
JDVSX16.42N/A
N/A
JPMorgan Diversified I
FWOEX17.11N/A
N/A
Fidelity Advisor Women's Leadership M

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with XNCR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+4.60%
XNCR - BCYC
55%
Loosely correlated
+4.16%
RPTX - BCYC
51%
Loosely correlated
+7.75%
RLAY - BCYC
50%
Loosely correlated
+1.13%
INO - BCYC
48%
Loosely correlated
+0.75%
RCUS - BCYC
45%
Loosely correlated
+3.41%
More

TVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVTX has been loosely correlated with CRNX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TVTX jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVTX
1D Price
Change %
TVTX100%
+4.76%
CRNX - TVTX
43%
Loosely correlated
+1.07%
XNCR - TVTX
43%
Loosely correlated
+4.16%
RLAY - TVTX
42%
Loosely correlated
+1.13%
COGT - TVTX
40%
Loosely correlated
+4.60%
BCYC - TVTX
39%
Loosely correlated
+4.60%
More